Entity Common Stock, Shares Outstanding of INOVIO PHARMACEUTICALS, INC. from 27 Jul 2011 to 07 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
INOVIO PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 27 Jul 2011 to 07 Nov 2025.
  • INOVIO PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 07 Nov 2025 was 53,571,675, a 105% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 53,571,675 +27,471,684 +105% 07 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 53,142,661 +27,178,393 +105% 08 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 36,667,221 +13,296,856 +57% 12 Mar 2025 10-K 18 Mar 2025 2024 FY
Q3 2024 26,099,991 -246,886,433 -90% 12 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 25,964,268 -242,110,601 -90% 08 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 23,370,365 -236,761,621 -91% 01 Mar 2024 10-K 06 Mar 2024 2023 FY
Q3 2023 272,986,424 +23,497,160 +9.4% 08 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 268,074,869 +18,674,392 +7.5% 07 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 260,131,986 +42,728,699 +20% 24 Feb 2023 10-K 01 Mar 2023 2022 FY
Q3 2022 249,489,264 +39,103,387 +19% 07 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 249,400,477 +39,043,581 +19% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 217,403,287 +9,770,703 +4.7% 25 Feb 2022 10-K 01 Mar 2022 2021 FY
Q3 2021 210,385,877 +40,976,898 +24% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 210,356,896 +42,836,461 +26% 06 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 207,632,584 +61,829,498 +42% 26 Feb 2021 10-K 01 Mar 2021 2020 FY
Q3 2020 169,408,979 +69,398,651 +69% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 167,520,435 +68,492,663 +69% 07 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 145,803,086 +48,166,722 +49% 11 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 100,010,328 +4,663,264 +4.9% 07 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 99,027,772 +7,530,937 +8.2% 05 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 97,636,364 +7,232,511 +8% 08 Mar 2019 10-K 12 Mar 2019 2018 FY
Q3 2018 95,347,064 +5,050,900 +5.6% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 91,496,835 +1,269,661 +1.4% 03 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 90,403,853 +16,302,473 +22% 08 Mar 2018 10-K 14 Mar 2018 2017 FY
Q3 2017 90,296,164 +16,235,634 +22% 03 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 90,227,174 +16,678,832 +23% 04 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 74,101,380 +1,877,355 +2.6% 08 Mar 2017 10-K 15 Mar 2017 2016 FY
Q3 2016 74,060,530 +1,877,283 +2.6% 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 73,548,342 +1,431,531 +2% 01 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 72,224,025 +11,482,943 +19% 07 Mar 2016 10-K 14 Mar 2016 2015 FY
Q3 2015 72,183,247 +11,592,165 +19% 02 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 72,116,811 +11,717,821 +19% 03 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 60,741,082 -178,868,678 -75% 09 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 60,591,082 -147,785,387 -71% 03 Nov 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 60,398,990 -129,504,456 -68% 04 Aug 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 239,609,760 +59,688,523 +33% 07 Mar 2014 10-K 17 Mar 2014 2013 FY
Q3 2013 208,376,469 +69,012,689 +50% 04 Nov 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 189,903,446 +54,935,052 +41% 08 Aug 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 179,921,237 +44,952,843 +33% 08 Mar 2013 10-K 18 Mar 2013 2012 FY
Q3 2012 139,363,780 +12,095,098 +9.5% 02 Nov 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 134,968,394 +7,711,487 +6.1% 02 Aug 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 134,968,394 04 May 2012 10-Q 09 May 2012 2012 Q1
Q3 2011 127,268,682 26 Oct 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 127,256,907 27 Jul 2011 10-Q 05 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.